Creative B2B marketing, communications and branding. Trend scout at the intersection of industry and design.
Making rare disease drug development happen, and happen faster, by looking at rare disease drug development paradigms, and how to shift them. All explained in Volv Global SA's talk at the World Orphan Drug Congress Europe 2024, next Wednesday - see you there!
You can't understand what's really important to the people in the healthcare ecosystem without talking to them directly. For a few years now, Volv Global SA has been consulting with key stakeholders on the challenges and what's needed to change the paradigms for rare disease drug development. At the World Orphan Drug Congress Europe 2024, our CEO 💭 Christopher Rudolf will present our findings to-date! "Drive for change: paradigm shifts to accelerate rare disease drug development" - Wednesday, 23rd October, 4.10 p.m., at Theater 5 (Precision Medicine track). Details in the comments! #driveforchange #paradigmshift #drugdevelopment #raredisease #orphandrug #volvglobal #christopherrudolf #wodc2024 #worldorphandrugcongress
